NDA submission for Starpharma’s VivaGel® BV

21 November 2017

BioSpectrum Asia reported on Starpharma’s NDA submission for VivaGel® BV, noting that Starpharma is one of the few Australian companies to take a locally developed product to this stage.

Go to article


About Starpharma

This document contains Forward Looking Statements

For Further Information


© Starpharma Holdings Limited 2017